By explaining all the terms related to Kushtha(Skin disease) and compare the Malkangni Apamarga Kshara Tail with standard drug miconazole in Sidhma Kushtha(Fungal infection)

Explorative Study Of Terminologies Used In Relation To Kushtha In Classics And Evaluation Of Malkangni Apamarga Kshara Tail(Consecutive Study) With Standard Drug Miconazole In Sidhma Kushtha(Pityriasis Versicolor)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054350

Enrollment

Registered

2023-06-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with clinical signs of the disease Sidhma Kushtha as per Ayurvedic classics and Pityriasis Versicolor in modern dermatology.i.e Shweta Varna (Hypopigmented macules) Rajo Ghrishtum Vimunchyati (Furfuraceous scales, Powdery) Tamra Varna (Copper coloured macules) Alabupushpa Varna (Hypopigmented macules) Kandu (Itching) Urdhva Kaya especially Uras (chest, trunk or neck). 3.Patients found positive and negative for KOH will also be included in the trial. 4. Patients willing and able to participate in the trial. 5. Patients between age group of 12-60 years irrespective of gender, religion, occupation. and chronicity will be selected for the study.

Exclusion criteria

Exclusion criteria: 1.Presence of any other skin ailment on the chest trunk or neck(or defined site of pityriasis versicolor). 2. Patients not willing to participate in the trial. 3. Patients whose age is less then 12yrs and above 60yrs. 4. Pregnancy,lactating women and puerperium. 5 Failure of Patients to follow up successive visits.

Design outcomes

Primary

Measure	Time frame
Overall improvement which will be shown by the patients in signs and symptoms.Timepoint: 60 days	—

Secondary

Measure	Time frame
Overall improvement which will be shown by the patients in signs & symptomsTimepoint: 75 days	—

Countries

India

Contacts

Public ContactPranya brat sharma

Rajiv Gandhi government post garduate ayurvedic College & Hospital Paprola

satishgandharve@gmail.com7018241280

Outcome results